PL2949658T3
Peptides that specifically bind HGF receptor (cMet) and uses thereof
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
24 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24
46 members in 11 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 45158803 | United States of America | P | |
| 04716901 | European Patent Office (EPO) | A | |
| 08008144 | European Patent Office (EPO) | A | |
| 10185426 | European Patent Office (EPO) | A | |
| 15157779 | European Patent Office (EPO) | A | |
| 2004006473 | United States of America | W | |
| 151577798 | – | – | – |
| 451588P | – | – | – |
| EP20040716901 | – | – | – |
| EP20080008144 | – | – | – |
| EP20100185426 | – | – | – |
| EP20150157779 | – | – | – |
| US20030451588P | – | – | – |
| WO2004US06473 | – | – | – |
Members46
| Document | Office | Kind | |
|---|---|---|---|
| AU2004217894A1 | Australia | A1 | |
| CA2517939A1 | Canada | A1 | |
| WO2004078778A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004078778A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2005214859A1 | United States of America | A1 | |
| EP1603935A2 | European Patent Office (EPO) | A2 | |
| EP1603935A4 | European Patent Office (EPO) | A4 | |
| JP2007524598A | Japan | A | |
| EP1944312A1 | European Patent Office (EPO) | A1 | |
| AU2004217894B2 | Australia | B2 | |
| US2010260672A1 | United States of America | A1 | |
| US2010261875A1 | United States of America | A1 | |
| AU2010235865A1 | Australia | A1 | |
| EP2284180A2 | European Patent Office (EPO) | A2 | |
| JP2011037872A | Japan | A | |
| EP2284180A3 | European Patent Office (EPO) | A3 | |
| US8044175B2 | United States of America | B2 | |
| US2011311446A1 | United States of America | A1 | |
| US2012039802A1 | United States of America | A1 | |
| EP1944312B1 | European Patent Office (EPO) | B1 | |
| AU2012241087A1 | Australia | A1 | |
| AU2010235865B2 | Australia | B2 | |
| PL1944312T3 | Poland | T3 | |
| ES2396368T3 | Spain | T3 | |
| JP5466350B2 | Japan | B2 | |
| JP2014159434A | Japan | A | |
| US9000124B2 | United States of America | B2 | |
| AU2015201413A1 | Australia | A1 | |
| AU2012241087B2 | Australia | B2 | |
| US2015218218A1 | United States of America | A1 | |
| EP2284180B1 | European Patent Office (EPO) | B1 | |
| CA2517939C | Canada | C | |
| EP2949658A2 | European Patent Office (EPO) | A2 | |
| DK2284180T3 | Denmark | T3 | |
| EP2949658A3 | European Patent Office (EPO) | A3 | |
| JP5876644B2 | Japan | B2 | |
| JP2017019787A | Japan | A | |
| AU2015201413B2 | Australia | B2 | |
| JP6216280B2 | Japan | B2 | |
| US9845340B2 | United States of America | B2 | |
| EP2949658B1 | European Patent Office (EPO) | B1 | |
| JP6374913B2 | Japan | B2 | |
| DK2949658T3 | Denmark | T3 | |
| PT2949658T | Portugal | T | |
| PL2949658T3This record | Poland | T3 | |
| HUE039154T2 | Hungary | T2 |
Numbers
- Publication
- 2949658
- Publication, DOCDB
- 2949658
- Publication, EPODOC
- PL2949658T
- Application
- 15157779
- Application, DOCDB
- 15157779
- Application, EPODOC
- PL20150157779T
Titles2
- English
- Peptides that specifically bind HGF receptor (cMet) and uses thereof
- Polish
- PEPTYDY SPECYFICZNIE WIAZACE SIE Z RECEPTOREM HGF (cMET) I ICH ZASTOSOWANIA
Classification
- CPC, 12
- C07K7/08
- A61K47/543
- A61K47/60
- A61K47/665
- A61K49/0043
- A61K49/0056
- A61K51/08
- A61P35/00
- A61P43/00
- B82Y5/00
- C07K14/4753
- C07K14/00